Ballestri at al.25 researched that relationship of serum Fetuin-A leves with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography; reported that BMI, waist circumference, TGs levels, fasting glucose, HOMA, spleen area, and SAT thickness, as well as the prevalence of metabolic derangements (hyperlipidemia, DM, and MetS) were significantly higher in NAFLD patients. Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.